Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Protein linked with Alzheimer's disease affects different brain cells differently

Protein linked with Alzheimer's disease affects different brain cells differently

Reducing sedentary behavior may be possible target to improve brain health

Reducing sedentary behavior may be possible target to improve brain health

People with TBI have increased risk of developing dementia

People with TBI have increased risk of developing dementia

Study explores relationship between age at menopause and memory

Study explores relationship between age at menopause and memory

Is there such a thing as normal aging?

Is there such a thing as normal aging?

Experts develop biology-based research framework for Alzheimer’s

Experts develop biology-based research framework for Alzheimer’s

Experts develop biology-based research framework for Alzheimer’s

Experts develop biology-based research framework for Alzheimer’s

ALS and frontotemporal dementia share genetic connections

ALS and frontotemporal dementia share genetic connections

Study reveals how apoE4 gene confers risk for Alzheimer's disease in brain cells

Study reveals how apoE4 gene confers risk for Alzheimer's disease in brain cells

Antiepileptic drug use linked to increased risk of Alzheimer's and dementia

Antiepileptic drug use linked to increased risk of Alzheimer's and dementia

Insilico to present recent advances in AI for aging biomarkers and age management research

Insilico to present recent advances in AI for aging biomarkers and age management research

New blood test can detect early indicators of Alzheimer's disease

New blood test can detect early indicators of Alzheimer's disease

Parkinson's patients who show depression symptoms may actually have demoralization, study says

Parkinson's patients who show depression symptoms may actually have demoralization, study says

Training programs tailored to address specific memory difficulty can be effective, study suggests

Training programs tailored to address specific memory difficulty can be effective, study suggests

UD researcher investigates role of new compound in fighting age-related diseases

UD researcher investigates role of new compound in fighting age-related diseases

UC San Diego Health designated as LBDA Research Center of Excellence

UC San Diego Health designated as LBDA Research Center of Excellence

Long-term consumption of caffeine has negative effects for Alzheimer's disease

Long-term consumption of caffeine has negative effects for Alzheimer's disease

New PET imaging agent could help guide treatments for people with neurological diseases

New PET imaging agent could help guide treatments for people with neurological diseases

Researcher finds that shape of misfolded proteins may contribute to Alzheimer’s, Parkinson’s and Huntington’s disease

Researcher finds that shape of misfolded proteins may contribute to Alzheimer’s, Parkinson’s and Huntington’s disease

Study reveals how interneurons emerge and diversify in the brain

Study reveals how interneurons emerge and diversify in the brain

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.